Cargando…

Pharmacophore-Based Similarity Scoring for DOCK

[Image: see text] Pharmacophore modeling incorporates geometric and chemical features of known inhibitors and/or targeted binding sites to rationally identify and design new drug leads. In this study, we have encoded a three-dimensional pharmacophore matching similarity (FMS) scoring function into t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Lingling, Rizzo, Robert C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306494/
https://www.ncbi.nlm.nih.gov/pubmed/25229837
http://dx.doi.org/10.1021/jp506555w
_version_ 1782354331991801856
author Jiang, Lingling
Rizzo, Robert C.
author_facet Jiang, Lingling
Rizzo, Robert C.
author_sort Jiang, Lingling
collection PubMed
description [Image: see text] Pharmacophore modeling incorporates geometric and chemical features of known inhibitors and/or targeted binding sites to rationally identify and design new drug leads. In this study, we have encoded a three-dimensional pharmacophore matching similarity (FMS) scoring function into the structure-based design program DOCK. Validation and characterization of the method are presented through pose reproduction, crossdocking, and enrichment studies. When used alone, FMS scoring dramatically improves pose reproduction success to 93.5% (∼20% increase) and reduces sampling failures to 3.7% (∼6% drop) compared to the standard energy score (SGE) across 1043 protein–ligand complexes. The combined FMS+SGE function further improves success to 98.3%. Crossdocking experiments using FMS and FMS+SGE scoring, for six diverse protein families, similarly showed improvements in success, provided proper pharmacophore references are employed. For enrichment, incorporating pharmacophores during sampling and scoring, in most cases, also yield improved outcomes when docking and rank-ordering libraries of known actives and decoys to 15 systems. Retrospective analyses of virtual screenings to three clinical drug targets (EGFR, IGF-1R, and HIVgp41) using X-ray structures of known inhibitors as pharmacophore references are also reported, including a customized FMS scoring protocol to bias on selected regions in the reference. Overall, the results and fundamental insights gained from this study should benefit the docking community in general, particularly researchers using the new FMS method to guide computational drug discovery with DOCK.
format Online
Article
Text
id pubmed-4306494
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-43064942015-09-17 Pharmacophore-Based Similarity Scoring for DOCK Jiang, Lingling Rizzo, Robert C. J Phys Chem B [Image: see text] Pharmacophore modeling incorporates geometric and chemical features of known inhibitors and/or targeted binding sites to rationally identify and design new drug leads. In this study, we have encoded a three-dimensional pharmacophore matching similarity (FMS) scoring function into the structure-based design program DOCK. Validation and characterization of the method are presented through pose reproduction, crossdocking, and enrichment studies. When used alone, FMS scoring dramatically improves pose reproduction success to 93.5% (∼20% increase) and reduces sampling failures to 3.7% (∼6% drop) compared to the standard energy score (SGE) across 1043 protein–ligand complexes. The combined FMS+SGE function further improves success to 98.3%. Crossdocking experiments using FMS and FMS+SGE scoring, for six diverse protein families, similarly showed improvements in success, provided proper pharmacophore references are employed. For enrichment, incorporating pharmacophores during sampling and scoring, in most cases, also yield improved outcomes when docking and rank-ordering libraries of known actives and decoys to 15 systems. Retrospective analyses of virtual screenings to three clinical drug targets (EGFR, IGF-1R, and HIVgp41) using X-ray structures of known inhibitors as pharmacophore references are also reported, including a customized FMS scoring protocol to bias on selected regions in the reference. Overall, the results and fundamental insights gained from this study should benefit the docking community in general, particularly researchers using the new FMS method to guide computational drug discovery with DOCK. American Chemical Society 2014-09-17 2015-01-22 /pmc/articles/PMC4306494/ /pubmed/25229837 http://dx.doi.org/10.1021/jp506555w Text en Copyright © 2014 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Jiang, Lingling
Rizzo, Robert C.
Pharmacophore-Based Similarity Scoring for DOCK
title Pharmacophore-Based Similarity Scoring for DOCK
title_full Pharmacophore-Based Similarity Scoring for DOCK
title_fullStr Pharmacophore-Based Similarity Scoring for DOCK
title_full_unstemmed Pharmacophore-Based Similarity Scoring for DOCK
title_short Pharmacophore-Based Similarity Scoring for DOCK
title_sort pharmacophore-based similarity scoring for dock
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306494/
https://www.ncbi.nlm.nih.gov/pubmed/25229837
http://dx.doi.org/10.1021/jp506555w
work_keys_str_mv AT jianglingling pharmacophorebasedsimilarityscoringfordock
AT rizzorobertc pharmacophorebasedsimilarityscoringfordock